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Oxidative  Damage  and  Erythrocyte  Membrane  Transport 
Abnormalities  in  Thalassemias 
By Oliviero Olivieri, Lucia De Franceschi, Maria D. Capellini, Domenico Girelli, 
Roberto Corrocher, and Carlo Brugnara 
Oxidative damage  induced by free globin  chains  has  been 
implicated in  the pathogenesis  of the membrane abnormali- 
ties observed in a and B thalassemia. We have evaluated 
transport of Na+ and K+ in erythrocytes of patients with 
thalassemias as well as in two experimental models that 
use normal human red blood cells, one for a thalassemia 
(methylhydrazine treatment, a thalassemia like) and one  for 
/3 thalacurmia (phenylhydrazine treatment, /3 thalassemia 
like). With the exception of the Na-K pump, similar alter- 
ations in membrane transport were observed in thalassemia 
and  thalassemia-like  erythrocytes.  These were: increased K- 
Cl cotransport, Na-Li countertransport  and  reduced  Na-K-Cl 
HEREAS MOLECULAR DEFECTS responsible for 
decreased globin chain synthesis in thalassemias 
have been described in great detail, the membrane damage 
imposed by the presence of free a or p chains is complex 
and less well characterized. Morphologic, biochemical, and 
metabolic changes of the erythrocyte membrane contribute to 
the premature destruction of thalassemic erythrocytes. Thus, 
membrane damage represents an important mechanism lead- 
ing to anemia in thala~semias."~ 
Previous studies in thalassemic erythrocytes have shown 
several alterations in membrane lipids and an 
increase in globin binding to membrane skeleton' and a de- 
crease in membrane  thiol^.^" a and p thalassemias are char- 
acterized by different membrane skeleton protein abnormali- 
ties and different cell deformability features.6s7 Many of these 
alterations are suggestive of an increased cell oxidative dam- 
age?.' 
One of the features that distinguishes severe p from a 
thalassemia is the presence of erythrocyte dehydration? p 
thalassemia minor red blood cells (RBCs) were shown to 
lose potassium (K+) after incubation in serumg or in autolo- 
gous plasma," probably as a consequence of the activation 
of the Gardos pathway induced by adenosine triphosphate 
(ATP) depletion and increased Ca influx.'' Studies by Nathan 
et a l l z  suggested a relationship between this abnormal K+ 
leak and hemoglobin (Hb) precipitation on the membrane. 
Studies in sickle cell anemia, where cellular dehydration is 
prominent, have shown a marked activation of the K-Cl 
~0transport.l~"~ This system induces K+ loss and cell shrink- 
age when the cells are swollen or exposed to acid 
[(Dihydro-indenyl) oxy] Alkanoic acid (DIOA), a specific 
inhibitor for this systern,l6 is effective in reducing K+ loss 
induced by  K-Cl cotransport both  in normalI7 and in oxygen- 
ated17 or deoxygenated sickle cells." K-Cl cotransport is 
also found in reticulocyte-rich but not in mature fractions of 
normal human RBCs." The activation of K-Cl cotransport 
observed in S S  and CC RBCs cannot be explained exclu- 
sively on the basis of an increased number of reticulocytes. 
Increased K-Cl cotransport has been reported in P-thalas- 
semia RBCsZo and in erythrocytes containing positively 
charged Hb variants in p6 and p?." Oxidation leads to acti- 
vation of K-Cl cotransport in normal human RBCs" and 
rabbit erythrocytes.22 
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cotransport. The Na-K pump was reduced in thalassemia- 
like cells, whereas it was increased in severe a thalassemia 
and in thalassemia cells. The increased K-Cl cotransport 
activity could be observed in light and  dense  fractions of /3- 
thalassemic cells.  K-Cl cotransport in thalassemic  and thal- 
assemia-like  erythrocytes was partially inhibited by  [(dihy- 
dro-indenyl) oxy] alkanoic  acid  and  completely  abolished by 
dthiothreitol. Thus, oxidative damage represents an im- 
portant factor in the increased  activity of the K-Cl  cotrans- 
port observed in thalassemias,  and  of the K+ loss observed 
in B-thalassemia  erythrocytes. 
0 1994 by The  American Society of Hematology. 
Some of the features of the membrane damage observed 
in thalassemic RBCs can be reproduced by incorporating 
free a chains into normal RBCs, with the dialysis exchange 
hemolysis techniq~e . '~ .~  An excess of denatured a or p Hb 
chains with associated iron, heme, or hemichromes' is re- 
sponsible for the generation of free radicals leading to the 
oxidative damage of the cell membrane in thalassemic 
RBCs.'.' Schrier and Mohandas have shown that the mem- 
brane protein abnormalities observed in severe or a thalas- 
semia can be reproduced in normal RBCs by exposure to 
the oxidants phenylhydrazine (PHZ) and methylhydrazine 
(MHZ), respectively (p- and a-thalassemia-like cells'). 
In this paper, we examined the principal RBC cation trans- 
port pathways in a- and &thalassemic RBCs. The effects on 
membrane transport of PHZ and MHZ treatment of normal 
human RBCs were also studied as well as those of DIOA 
and dithiothreitol (Dm) treatment. 
MATERIALS AND METHODS 
Drugs and chemicals. NaCl and KC1 were  purchased  from  Mal- 
linckrodt,  Inc, St Louis, MO. NaN03, albumin (bovine  fraction V), 
TRIS(hydroxymethy1)aminomethane (TRIS), 3 (N-morpholino)  pro- 
panesulfonic acid (MOPS), 2 (N-morpholino) ethanesulfonic acid, 
ouabain,  sucrose,  nystatin,  bumetanide, DTT, PHZ, and MHZ were 
purchased  from  Sigma  Chemical CO, St Louis,  MO. MgC12, 
Mg(NO& and dimethylsulfoxide  were  purchased  from  Fisher  Scien- 
tific CO, Fair Lawn, NJ. DIOA was purchased from Research Bio- 
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chemicals Inc, Natick, MA. Okadaic acid (OKA) was purchased 
from Kamiya Biomedicals (Thousand Oaks, CA). All solutions were 
prepared using double-distilled water. 
Patients. Informed consent was obtained from control subjects 
and patients. Blood was drawn after overnight fasting into heparin- 
ized tubes and processed within 24 hours. Sixteen heterozygous p-  
thalassemic (p-thalassemia minor or p-thalassemia trait) were stud- 
ied. Six severe &thalassemia patients were studied; they included 
two patients with Cooley's anemia (IVS-I n.6nVS-1 n.6; one 9 
months old, Hb 7.3 g/dL, mean corpuscular volume [MCV] 60 fL; 
the other 12 years old, untransfused because of multiple RBC alloan- 
tibodies, Hb 7.5  g/dL,  MCV 64 a), and four patients with P-thalas- 
semia intermedia (p"39/p"39;  Hb: 8.3, 8.5, 8.4, 9.1 g/dL;  MCV 62, 
73,60,67 a, respectively; two of these patients had been splenecto- 
mized). Three patients with a-thalassemia trait were studied (a-thal- 
I ;  -a3 '; Hb:  15.1, 12.4,10.2 g/dL;  MCV: 73,80,82 &, respectively). 
Three patients with Hb H disease (a  am/--; Hb: 9.4, 9.9, 9.2 g/dL; 
MCV: 61,62,66 fL, respectively) were studied. None of the patients 
had received blood transfusions in  the preceding 2 months. 
Cation transport measurements. Plasma and  buffy coat were 
removed after centrifugation at 1,200g for 10 minutes and  the cells 
washed four times with a choline wash solution (CWS) containing 
152 mmol/L choline chloride, 1 mmom MgCIZ, 10 mmol/L TRIS- 
MOPS), pH  7.40 at 4°C.  An aliquot of cells was then suspended in 
approximately equal volume of CWS, and determinations of hemato- 
crit, cell Na (150 dilution), and K (1:5O0 dilution) were performed. 
Erythrocyte Na+ and K+ contents were quantified by atomic absorp- 
tion spectrophotometry with standards made in double-distilled wa- 
ter. 
The maximal rates of  Na-K pump and  Na-K-Cl cotransport activ- 
ity were measured in cells containing equal amounts of Na and K 
(50 mmol/L of cells, obtained with nystatin technique). With this 
procedure the internal sites for both transport system are ~aturated.'~ 
The nystatin-loadmg solution contained 70  mmom NaCI, 70 mmoU 
L KCI, and 55 mmoVL sucrose. Na-K pump was estimated as the 
oubain-sensitive fraction on  Na+ efflux into a media containing 130 
mmol/L choline chloride and 10 mmol/L KCI. Triplicate samples 
were incubated for 5 minutes and 25 minutes at 37°C. The ouabain 
concentration was 0.1 mrnol/L. Na-K-Cl cotransport was estimated 
as the bumetanide-sensitive fraction of the Na+ and K+ efflux into 
a media containing 140 mmoVL choline chloride and 0.1 mmol/L 
ouabain. The efflux times were 5 minutes and 25 minutes at 37°C 
with triplicate samples. The bumetanide concentration was 0.01 
mmol/L. All media contained 1 mmol/L MgClz, I O  mmol/L glucose, 
and 10 mmol/L TIUS-MOPS (pH 7.4 at 37°C). 
K-Cl cotransport from fresh cells was measured as either chloride- 
dependent or volume-dependent K+ efflux. Flux media for chloride- 
dependent K efflux containing 1 0 0  mmoVL Na'  and 1 mmo& MgZ* 
(the anion being either Cl- or NO;), 10 mmol/L glucose and 10 
mmol/L TRIS-MOPS (pH 7.4 at 37°C). Chloride-dependent K' ef- 
flux  was calculated as the difference between K' efflux in chloride 
and nitrate media. Swelling-induced K+ flux was calculated as the 
difference between K' efflux in NaCl hypotonic ( I O 0  mol/L)  and 
in NaCl isotonic (140 mmol/L) media. Incubation times at 37°C for 
flux measurements were 5 and 25 minutes. DIOA was used at a 
final concentration of 0.1 mmol/L. 
When D'IT was used, thalassemic and oxidant-treated cells were 
washed  with CWS at  4°C and reincubated for additional 30 minutes 
at  37°C  in isotonic-buffered KC1 (130 mmol/L) solution containing 
10 mmolL D V .  After four washes with CWS at 4°C cells were 
used for K+ efflux measurements, as described above. 
Na-Li exchange was estimated as the external Na+-stimulated Li' 
efflux (differences between Li' efflux into 140 mmoVL NaCl and 
140 mmol/L choline chloride) from cells containing 20 m o l  Li+/ 
L cells. The nystatin procedure (loading solution with 110 mmol/L 
KCI, 30 mmom LiCl and 55 mmoVL sucrose) was  used  to  modify 
the red cell cation composition.'' 
Na-H exchange was estimated as the Na' efflux stimulated by 
hypertonic shrinkage (500 mOsrn) from cells containing equal 
amounts of  Na and K (nystatin technique). The media contained 140 
mmoVL choline chloride and the osmolarity was increased with 
sucrose. 5-(N,N-hexamethylene-amiloride 10 pmoVL final concen- 
tration) was  used  as  the specific inhibitor of  the system. All media 
contained 1 mmol/L MgC12, 10 m o V L  glucose, 10 mol/L TRIS- 
MOPS (pH 7.4 at 37"C), 0.1 mmoK ouabain and 10 pmol/L bumet- 
anide. 
Preparation of thalassemia-like cells. Human erythrocytes con- 
taining normal Hb were incubated at 10% hematocrit with different 
concentrations of PHZ and MHZ (from 0.5 to 10 mmol/L) in a 
medium containing 130 mmom KCI, 10 mmol/L NaCI, 1 mmol/L 
NaCI, 1 mmoI/L MgClz, 1 mmoVL K phosphate buffer, pH 7.4 and 
10 mmol/L glucose (60 min  at  37°C).  At  the  end  of  the incubation, 
cells were washed five times in CWS and then processed as described 
above to measure cation transport. When experiments with DTT 
were performed, the oxidized cells were reincubated for additional 
30 minutes at 37°C in isotonic buffered KC1 (130 mmol/L) solution 
containing 10 mmol/L DTT. After four washes with CWS at 4"C, 
cells were used for K' efflux measurement. In preliminary experi- 
ments, sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) analysis was performed after oxidative treatment and 
showed membrane protein abnormalities similar to those described 
by Schrier and  Mohandas.' 
Cell density separation. To obtain density-fractionated light 
cells (density < 1.096) and dense cells (density > 1 .l 14) discontinu- 
ous Percoll density gradient was used.z5 Density-separated cells were 
washed four times with CWS at  4°C  and immediately used for cation 
transport measurements, as described above. 
RESULTS 
Cation transport pathways in thalassemic erythrocytes. 
Hematologic data of the patients are summarized in Table 
1. Activities of the major cation transport pathways in eryth- 
rocytes of &thalassemic and a-thalassemic patients are 
shown in Figs 1A and 2A, respectively. To evaluate the 
relative magnitude of the changes in transport activities ob- 
served in thalassemic compared with normal cells, values 
were expressed as percentage of the control (= 100% of ac- 
tivity). The data were also corrected for the different volume 
of thalassemic cells as compared with  normal cells and are 
thus expressed based on a constant number of 1.1 X 10l3 
cells per liter of cells. Although quantitative differences were 
observed between a trait and Hb H disease, and between p 
trait and severe ,8 thalassemia, qualitatively similar results 
were obtained for all the cation transports irrespective of the 
pathologic condition considered (Figs 1A and 2A). The most 
relevant data were (1) substantial stimulation of K-Cl co- 
transport and  Na-Li countertransport; (2) a twofold increase 
of  Na-K pump (with the exception of the a-trait condition); 
and (3) a relevant reduction of the Na-K-Cl cotransport activ- 
ity (Figs 1A-2A). The Na-H exchange was not increased in 
either a- or ,&thalassemia RBCs (Figs 1A and 2A). 
The different effects on four transport systems (increased 
Na-K pump, K-Cl cotransport, Li countertransport, and de- 
creased Na-K-Cl cotransport) and the lack of an increase in 
Na-H exchange, that is known to be elevated in young 
cells,2"27 indicate that cell age is not the only determinant 
for the increased rate of transport observed in thalassemic 
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Table 1. Hematoloaic Data of Normal  Controls  and Thalassemic Patients 
Cell Na Cell K Cell Na + K Reticulocytes 
Hb WdL) Hct (%) (rnrnolikg Hb) Irnrnollkg Hbl (rnrnolikg Hb) (96) 
Control (n = 161 13.4 t 3.4 45.1 t 5.1 40 t 4.8 331 t 39.3 372 f 29.3 1.5 t 0.3 
trait  (n = 16) 11.4 t 2.7 39.2 t 4.9 33 e 8.1 255 t 42.3 288 t 13.4 5.4 t 1.3 
0 severe (n = 6) 8.2 t 0.7 28.5 2 3.4 33 r 6.8 204 f 26.3 239 f 15.6 20 e 4.7 
n trait  (n = 3) 12.6 e 2.5 38.3 c 5.3 38 t 7.5 308 t 35 346 t 27.5 2 t 0.9 
Hb H (n = 3) 9.5 t 0.4 33.1 t 6.7 37 r 7.2 293 t 27.1 330 t 25.4 4.2 t 1.4 
Data are expressed as mean t SD. 
RBCs. Thus, studies in normal RBCs rendered thalassemia- 
like by exposure to PHZ or MHZ were performed to deter- 
mine the effect of oxidative damage. 
Cation transports properties of thalassemia-like RBCs. 
The mean values of the activities of the major RBC cation 
transport pathways in normal erythrocytes treated with dif- 
ferent concentrations of PHZ or MHZ (p- or a-thalassemia- 
like erythrocytes, respectively) are shown in Figs 1B and 
2B. 
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Fig 1. (A) The principal  cation  transport  pathways of human  eryth- 
rocytes in normal control, p-thalassemia  trait,  and severe p thalas- 
semia (B-thalassemia severe). Results expressed as mean f SD (n = 
6). (B) The principal  cation  transport  pathways of human  erythrocytes 
in p-thalassemia-like RBCs (normal RBCs treated with PHZ). Results 
expressed as mean f SD In = 31. 
Exposure of erythrocytes to PHZ-  and MHz-induced 
changes in cation transport qualitatively similar to  those of 
p and a thalassemia. The only noteworthy difference con- 
cerned the Na-K pump, which was strongly inhibited after 
exposure to both oxidant drugs (Figs IB and 2B). 
Changes in the transport activities were progressively 
more evident with increasing concentrations of the oxidants. 
For PHZ-treated erythrocytes, concentrations of 5 mmol/L 
yielded changes of  Na-Li countertransport, Na-K-Cl  and K- 
Cl cotransport activities similar to those of &thalassemic 
cells (Fig IB); at this concentration, Na-H exchange was 
Control 
alpha-thal t n i t  
I 
Na pump Na/H 
1mMMHZ 
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I 
K/CI 
r' 
Fig 2. The principal  cation  transport  pathways of human  erythro- 
cytes in normal control, a-thalassemia trait, Hb  H disease (A) (results 
expressed as mean f SDI, and a-thalassemia-like RBCs (normal 
RBCs treated  with MHZI (B), [results expressed as mean f SD (n = 
311. 
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Table 2. K-Cl Cotransport in Density-Fractionated Normal  Control 
and Thalassemic Erythrocytes 
K-Cl Cotransport (mmol/L cell x h) 
Control 0 Trait Severe a Trait Hb H 
(n = 3) (n = 3) (n = 3) (n = 3) (n = 3) 
TOP 2.5 z 1.6 8.0 2 2.3 14.6 2 3.1 5.8 -t 1.7 6.9 t 2.9 
Bottom 0.7 2 0.9 3.0 2 1.1 10.9 2 2.1 3.8 ? 0.9 4.1 5 1.7 
Top fraction, density less than 1.096; bottom fraction, density greater than 
1.114. 
twofold stimulated,  whereas it was unaffected by  lower  con- 
centrations of PHZ (Fig IB). A progressive inhibition of the 
Na-K pump  was  observed  with  increasing concentrations  of 
PHZ (Fig 1B). 
For  a-thalassemia-like  rythrocytes,  exposure  to  5.7 
mmolL MHZ reproduced changes in Na-Li countertrans- 
port, Na-K-C1 and K-Cl cotransport activities, similar to 
those of a-thalassemic  cells;  at  these  and  higher concentra- 
tions, Na-H  exchange  was several-fold stimulated, whereas 
it was unaffected by lower  concentrations of MHZ (Fig  2B). 
Similarly to  PHZ,  Na-K  pump  was progressively inhibited 
by increasing concentrations of MHZ (Fig 2B). 
Properties of K-Cl cotransport in thalassemic erythro- 
cytes. In consideration of the markedly increased K loss 
through K-Cl cotransport  observed  in  0-thalassemia and P-  
thalassemia-like RBCs  (Fig l), additional experiments  were 
designed  to  elucidate  the bases for  the activation  of the  sys- 
tem in P thalassemia. Because K-Cl cotransport is repre- 
sented  mostly in  young  erythrocytes  and  reticulocyte^,'^ the 
observed  increased activity could  be a consequence of the 
presence of younger cells. However, if this  is  the  case,  the 
increased activity should still be limited to  the lightest den- 
sity fractions, as in  normal  human RBCs.I9  K-Cl cotransport 
was  measured  in density-fractionated cells  (top fraction, 
least-dense cells; bottom fraction, densest cells). Table 2 
shows that a sizable K-Cl cotransport was present in the 
dense fraction  of thalassemic cells, whereas  it  was  absent in 
the  dense  fraction of  normal cells.  Thus, inactivation of K- 
Cl  cotransport  in  cells of high density is  absent  in  thalassemic 
erythrocytes. Because  only  three  subjects  with  severe P tha- 
lassemia were studied, it was not possible to determine 
whether splenectomy affects the activity  of  K-Cl cotransport 
in the different  density  fractions. 
The susceptibility to inhibition by DIOA and OKA are 
well-recognized characteristic of K-Cl cotransport.“.” The 
short-term effects of DIOA  on  K-Cl  cotransport  (measured 
as chloride-dependent  or  volume-stimulated K  efflux) in a- 
and  P-thalassemia  erythrocytes  are  shown  in  Fig 3, A and 
B. About 50% of K-Cl cotransport was DIOA-sensitive in 
severe P thalassemia,  Hb H disease  and  P-thalassemia trait, 
whereas in a trait, the inhibition by DIOA was only 28% 
(Fig 3, A and B). Similar results were obtained on both 
p- and  a-thalassemia-like  erythrocytes  (PHZ = 5 mmolL, 
MHZ = 5.7  mmol/L) in  presence of DIOA  (Fig 3) and with 
the protein phosphatase inhibitor OKA (10 ymol/L). 
To evaluate  the  role of sulphycryl (SH)-groups oxidation 
on K-Cl cotransport in  thalassemia, K efflux was measured 
in thalassemia and thalassemia-like RBCs pretreated with 
the  reducing  agent  DTT (10 mmol/L). DTT strongly  reduced 
and almost normalized K+ efflux in both P- and a-thalas- 
semia  conditions  (Fig 4, A and B), as well as  in  thalassemia- 
like  erythrocytes (Fig 4, A and  B). 
DISCUSSION 
The  “membrane  lesion”  occurring  in thalassemias  is 
complex  and  not completely  understood. Among  the differ- 
ent changes observed, an altered cation membrane perme- 
ability has  been reported, but  the underlying mechanism  has 
not  been elucidated. As previously shown  by others;,’’ we 
found  that  erythrocyte  K+  content  was significantly reduced 
in P-thalassemia erythrocytes (Table 1). The transport of 
monovalent  cations  was  also altered  in a- and  P-thalassemia 
RBCs.  We  observed  (1) a very strong (fourfold to ninefold) 
stimulation of K-Cl cotransport  and  Na-Li countertransport; 
(2) a twofold increase of Na-K  pump  (with  the exception  of 
the  a-trait  condition); (3) a relevant reduction of the  Na-K- 
Cl cotransport activity and no changes in Na-H exchange 
activity (Figs  lA-2A).  It is worth  noting that K-Cl  cotrans- 
port was stimulated not  only in P thalassemia,” but  also in 
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Fig 3. Effects of DIOA  and okadaic acid (OKA) on RBC K-Cl cotrans- 
port.  (A) Effects on p trait, severe p-thalassemia erythrocytes, and 
p-thalassemia-like RBCs (PHZ, 5 mmol/L; results expressed as mean * SD; n = 4). (B) Effects of DIOA on ry trait,  Hb H, and ry-thalassemia- 
like  (MHZ, 5.7 mmol/L) erythrocytes [results expressed as mean k 
SD; n = 4). 
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Fig 4. Effect of D l T  treatment (10 mmol/L) on K-Cl cotransport. 
(AI Effect of D l T  in B trait, sevare p thalassemia, and B-thalassemia- 
like (PHZ, 5 mmol/L) arythrocytes. (B) Effect of DlT in Q trait, Hb  H, 
and a-thalassemia-like (MHZ, 5.7 mmol/L) erythrocytes. Data are 
expressed  as mean * SD (n = 4). 
a thalassemia (although to a smaller extent). Whereas these 
findings help to explain the relative dehydration of P-thalas- 
semia erythrocytes, they cannot account for the relative over- 
hydration of Hb H disease. The Ca-activated K channel 
(Gardos pathway”) was not part of these studies. It remains 
to be determined if the number of channel and their regula- 
tion  by internal Ca is altered in thalassemic cells. 
The relevant alterations of membrane transport observed 
in thalassemia RBCs could be reproduced in  normal RBCs 
treated with PHZ or MHZ (Figs 1 and 2) .  MHZ and PHZ 
produced well-defined changes on both membrane proteins 
(confirmed by SDS-PAGE analysis*) and membrane cation 
transport, which strongly mimicked the abnormalities in Na- 
Li countertransport, Na-K-Cl and K-Cl cotransport activities 
observed in a and 0 thalassemia. The only exception was 
represented by the activity of the Na-K pump, which was 
inhibited in oxidized erythrocytes (Fig 2). It is worth noting 
that in rabbit erythrocytes, oxidation decreases the Na-K 
pump activity, whereas cell age increases it.” The twofold 
stimulation of Na-K pump in thalassemia appears to be a 
consequence of two opposing processes: stimulation caused 
by the presence of younger cells and inhibition caused by 
concomitant oxidative membrane damage. In a previous re- 
port, 3H-ouabain binding studies on a- and P-thalassemia 
erythrocytes showed a 2.6- to 10-fold increase above nor- 
Because we have not measured the number of pumps 
in our patients, the relative effect of oxidative damage can 
not be determined. A discrepancy between increased pump 
sites and increased flux would suggest oxidative damage 
effect. The similarity between changes in membrane trans- 
port observed in thalassemia and thalassemia-like RBCs in- 
dicates that membrane damage rather than cell age is the 
main determinant of the changes we observed in thalassemia 
erythrocytes. 
We have shown here that P-thalassemia erythrocytes have 
increased K-Cl cotransportzo (Fig 1). Another distinguishing 
feature of @-thalassemia erythrocytes is that increased K- 
Cl cotransport was observed in the top and bottom density 
fractions of thalassemia RBCs (Table 2). K-Cl cotransport 
is usually observed in the least-dense, reticulocyte-rich frac- 
tion of normal RBCs, and is absent in denser fractions.” 
This finding is similar to previous reports in SS13 and  CCI5 
cells and indicates that cells with increased K-Cl cotransport 
are present throughout the density span of thalassemia RBCs. 
Thus, K-Cl cotransport is a major pathway for K loss and 
dehydration not only in SS and CC cells, but also in p- 
thalassemia erythrocytes. 
The role of oxidation in K-Cl cotransport activation is 
shown by the effects of DTT (Fig 4, A and B). Treatment 
with DTT reduced K-Cl cotransport in thalassemia erythro- 
cytes to values close to control. Thus, oxidation may repre- 
sent “a third factor” capable of modulating activation of 
K-Cl cotransport in addition to cell age and presence of 
p6-p7 positively charged mutations on Hb.” The effect of 
oxidation on K-Cl cotransport has been shown in experimen- 
tal models using normal cells,” is potentiated by exposure 
to NEMZ9 and can also be shown in rabbit erythrocytes.” 
Membrane oxidation plays a relevant role in the alterations 
of membrane cation transport observed in thalassemic RBCs. 
It is also a major factor in  the activation of K-Cl cotransport 
in thalassemic RBCs, which is an important determinant of 
the relative dehydration observed in P-thalassemia erythro- 
cytes. 
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